On Sept. 5, the FDA announced an import alert and green list for glucagon-like peptide-1 (GLP-1) active pharmaceutical ingredient (API) manufacturers. The FDA included manufacturers on the green list ...
India Ratings (Ind-Ra) predicts a recovery in API prices for FY27, driven by India's Minimum Import Price (MIP) and China’s withdrawal of export VAT rebates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results